Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$379,019
+$134,361 QoQ
Shares Held
316
+18.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#3,982
of 4,605 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hollow Brook Wealth Management LLC holds $18,211,815 across 8 Drug Manufacturers - General names. LLY ranks #8 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
41,158 | $10,452,897 | |
| 2 | PFE |
Pfizer Inc
|
196,805 | $4,739,064 | |
| 3 | ABBV |
AbbVie Inc.
|
2,525 | $635,391 | |
| 4 | NVS |
Novartis AG
|
3,788 | $593,655 | |
| 5 | MRK |
Merck & Co., Inc.
|
4,113 | $528,520 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,546 | $448,001 | |
| 7 | AMGN |
Amgen Inc
|
1,202 | $435,268 | |
| 8 | LLY |
ELI LILLY & Co
This page
|
316 | $379,019 |
All Filings in LLY
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $379,019 | 316 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $244,658 | 266 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $285,864 | 266 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $202,958 | 266 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $207,354 | 266 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $219,692 | 266 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $205,352 | 266 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $425,251 | 480 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $235,398 | 260 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $210,049 | 270 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||